Geneva, June 22 -- International Clinical Trials Registry received information related to the study (ISRCTN84887953) titled 'Magnesium deficiency and vascular complications in type 1 diabetes' on June 9.
Study Type: Interventional
Study Design:
Allocation: Randomized controlled trial
Masking: Blinded (masking used)
Control: Placebo
Assignment: Crossover
Purpose: Treatment
Primary Sponsor: University of Leeds
Condition:
Magnesium deficiency as a reversible driver of vascular complications in patients with type 1 diabetes
Nutritional, Metabolic, Endocrine
Intervention:
Magnesium supplement - 360mg magnesium bisglycinate. This will correspond to 2 'active magnesium-rich' tablets/capsules per day (will be taken orally, in a single si...